News & Updates
Filter by Specialty:
L-MOCA: Olaparib maintenance for ovarian cancer benefits Asians
Maintenance monotherapy with olaparib appears safe and effective in Asian patients with platinum-sensitive relapsed (PSR) ovarian cancer, regardless of their BRCA status, as shown in the results of the phase III, open-label, single-arm L-MOCA study.
L-MOCA: Olaparib maintenance for ovarian cancer benefits Asians
07 Jul 2022Diabetes status may influence long-term survival in metastatic breast cancer
Long-term overall survival (OS) in patients with metastatic breast cancer (MBC) may be influenced by diabetes status, according to a retrospective study presented at ENDO 2022.
Diabetes status may influence long-term survival in metastatic breast cancer
06 Jul 2022Chlorhexidine a safe, reasonable option for vaginal antisepsis
Vaginal antisepsis with chlorhexidine proves noninferior to that with iodine in terms of the incidence of gynaecologic surgery-associated urinary tract infection and vaginal irritation, as reported in a study.
Chlorhexidine a safe, reasonable option for vaginal antisepsis
06 Jul 2022Healthy plant-based diet may reduce breast cancer risk
Adherence to a healthy plant-based diet was tied to a reduced risk of breast cancer, according to a French study presented at Nutrition 2022. In contrast, an unhealthy plant-based diet may be tied to increased breast cancer risk.
Healthy plant-based diet may reduce breast cancer risk
04 Jul 2022Sexual assault, harassment may up hypertension risk in women
Experiencing sexual assault, sexual harassment at work, or both appear to increase a woman’s risk of developing hypertension over a long-term period, according to an analysis of the Nurses’ Health Study II.
Sexual assault, harassment may up hypertension risk in women
01 Jul 2022Mini-slings on par with mid-urethral slings for female SUI
In terms of patient-reported success, the newer, adjustable, anchored single-incision mini-slings (SIMS) were noninferior to the synthetic, tension-free, standard mid-urethral slings (SMUS) for the surgical management of stress urinary incontinence (SUI) in women, the SIMS study suggests.